Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1171087
PUBLISHER: Grand View Research | PRODUCT CODE: 1171087
Cell Viability Assays Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Application (Drug Discovery & Development, Stem Cell Research), By End-user, By Region, And Segment Forecasts, 2023 - 2030
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Cell Viability Assays Market Growth & Trends:
The global cell viability assays market size is expected to reach USD 3.01 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.94% from 2023 to 2030. The rising prevalence of chronic and infectious diseases and the increasing focus on cell-based therapeutics are expanding the growth prospects of the market. In addition, growing funding for cell-based research and increasing use of automated instruments are the key factors driving the market for cell viability assays (CVAs).
Increasing funding and investments for cell-based research are expanding growth prospects for cell viability assays. For instance, in May 2022, the California Institute for Regenerative Medicine (CIRM) announced an investment of USD 11 million to fund a cell therapy clinical trial testing to help throat cancer patients to heal from the devastating side effects of radiation therapy. Thus, increasing funding for cell-based research is predicted to boost market growth during the projection period.
Furthermore, major players are continuously developing sophisticated technologies to meet the rising demand and capture untapped opportunities. For instance, in April 2022, Molecular Devices, LLC introduced SpectraMax Mini Multi-Mode Microplate Reader for various applications, including cell viability. It is a compact and cost-effective solution integrated with data analysis software and protocol control for rapid data generation and analysis. Such technological innovations are anticipated to increase the adoption of CVAs in biotech and academic laboratories.
The COVID-19 pandemic is expected to positively influence market growth. The cell counting and viability assay are used to aid COVID-19 vaccine research. The most frequently used CVAs in COVID-19 research include Live/Dead (EarlyTox Live/Dead Assay Kit) staining, MTT assay, Transfection efficiency, and Cell viability (CellTiter-Glo Luminescent Cell Viability Assay). As a result, the usage of these assays is projected to increase due to the COVID-19 pandemic, which, in turn, is anticipated to boost the market growth.
The rising focus on the development of cell-based therapeutics is accelerating market growth. Increasing clinical trials, FDA approvals, and strategic initiatives such as collaborations by major players are boosting the market growth. For instance, in January 2022, Bristol Myers Squibb and Century Therapeutics entered into a research collaboration to develop four induced pluripotent stem cells for hematologic malignancies and solid tumors. Such initiatives are projected to increase the application of CVAs during the development of stem cell therapeutics, thereby propelling growth during the forecast years.
On the other hand, the high cost of reagents and limitations in the applicability of cell viability assay for 3D cell culture may restrict the market growth to a certain extent. For instance, while performing the cell viability assay in 3D cell culture, the assay regents may have difficulty reaching the center of microtissues. Thus, accurate results of the assay cannot be determined. However, key players are continuously striving for developing novel and cost-effective reagents and techniques to overcome the limitations, which is likely to create growth prospects for the market.
Cell Viability Assays Market Report Highlights:
- By product, the consumables segment held the largest share in 2022. This is attributed to the increase in the requirement of CVAs for pharmaceutical and biotechnology companies, stem cell research, and diagnostics, which, in turn, is likely to fuel the market growth
- By application, the drug discovery and development segment held the second-largest share in 2022. This is attributed to an increase in the applications of CVAs to estimate the cellular variations related to cell death during the drug discovery and development
- By end-user, the biopharmaceutical and pharmaceutical companies segment held the largest share in 2022 owing to the widespread use of cell viability assay in pharmaceuticals to evaluate the influence of developed agents on cells
- North America dominated the global market with over 35.0% share in 2022 due to a rise in investment initiatives by the government, increasing incidence of chronic diseases such as cancer, and the presence of high-quality infrastructure for clinical and laboratory research
- Asia Pacific is expected to grow considerably in the future owing to the rising demand for novel therapeutics, increasing R&D investment by governments, and rapid infrastructural development
Product Code: GVR-4-68040-008-0
Table of Contents
Chapter 1 Research Methodology
- 1.1 Market Segmentation & Scope
- 1.1.1 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Approach 1: Commodity flow approach
- 1.6.1.2 Approach 2: Country-wise market estimation using a bottom-up approach
- 1.6.1 Commodity Flow Analysis
- 1.7 Global Market: CAGR Calculation
- 1.8 Research Assumptions
- 1.9 List of Secondary Sources
- 1.10 List of Primary Sources
- 1.11 Objectives
- 1.11.1 Objective 1:
- 1.11.2 Objective 2:
- 1.12 List of Abbreviations
Chapter 2 Market Definitions
Chapter 3 Executive Summary
- 3.1 Market Summary
Chapter 4 Global Cell Viability Assay Market Variables, Trends, & Scope
- 4.1 Cell Viability Assay Market Lineage Outlook
- 4.1.1 Parent Market Outlook
- 4.2 Penetration and Growth Prospect Mapping
- 4.3 Regulatory Framework
- 4.4 Market Driver Analysis
- 4.4.1 Rising focus on the development of cell-based therapeutics
- 4.4.2 Growing funding for cell-based research
- 4.4.3 Technological advancements in cell viability assays
- 4.5 Market Restraint Analysis
- 4.5.1 High cost of reagents and instruments may limit the adoption of cell viability assays
- 4.5.2 Limitations in the applicability of cell viability assays for 3D cell culture
- 4.6 Market Opportunity Analysis
- 4.6.1 Growing emphasis on stem cell research
- 4.7 Porter's Five Forces Analysis
- 4.8 Cell Viability Assay Market: COVID-19 Impact Analysis
Chapter 5 Cell Viability Assay Market - Segment Analysis, by product, 2018 - 2030 (USD Million)
- 5.1 Global Cell Viability Assay Market: Product Movement Analysis
- 5.2 Consumables
- 5.2.1 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
- 5.2.2 Reagents and Assay Kits
- 5.2.2.1 Reagents and assay kits, by type market estimates and forecast, 2018 - 2030 (USD Million)
- 5.2.2.2 Dye exclusion assays
- 5.2.2.2.1 Dye exclusion assays market estimates and forecast, 2018 - 2030 (USD Million)
- 5.2.2.3 Colorimetric assays
- 5.2.2.3.1 Colorimetric assays market estimates and forecast, 2018 - 2030 (USD Million)
- 5.2.2.4 Fluorometric assays
- 5.2.2.4.1 Fluorometric assays market estimates and forecast, 2018 - 2030 (USD Million)
- 5.2.2.5 Luminometric assays
- 5.2.2.5.1 Luminometric assays market estimates and forecast, 2018 - 2030 (USD Million)
- 5.2.3 Microplates
- 5.2.2.1 Microplates market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3 Instruments
- 5.3.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.2 Spectrophotometer
- 5.3.2.1 Spectrophotometer market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.3 Microscopy
- 5.3.3.1 Microscopy market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.4 Cell Imaging and Analysis System
- 5.3.4.1 Cell imaging and analysis system market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.5 Flow Cytometry
- 5.3.5.1 Flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.6 Others
- 5.3.6.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6 Cell Viability Assay Market- Segment Analysis, by Application, 2018 - 2030 (USD Million)
- 6.1 Global Cell Viability Assay Market: Application Movement Analysis
- 6.2 Drug Discovery and Development
- 6.2.1 Drug discovery and development market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3 Stem Cell Research
- 6.3.1 Stem cell research market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4 Diagnostics
- 6.4.1 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7 Cell Viability Assay Market- Segment Analysis, by End-user, 2018 - 2030 (USD Million)
- 7.1 Cell Viability Assay Market: End-user Movement Analysis
- 7.2 Biopharmaceutical & Pharmaceutical Companies
- 7.2.1 Biopharmaceutical & pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3 CROs & CMOs
- 7.3.1 CROs & CMOs market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4. Academic & Research Institutes
- 7.4.1 Academic & research institutes market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5. Diagnostic Labs
- 7.5.1 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8 Cell Viability Assay Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)
- 8.1 Cell Viability Assay Market: Regional Movement Analysis
- 8.2 North America
- 8.2.1 SWOT Analysis
- 8.2.1.1 North America cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.2.1.2 North America cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.2.1.3 North America cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.2.2 U.S.
- 8.2.2.1 Key Country Dynamics
- 8.2.2.2 Target Disease Prevalence
- 8.2.2.3 Competitive Scenario
- 8.2.2.4 Regulatory Framework
- 8.2.2.5 Reimbursement Scenario
- 8.2.2.6 U.S. cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.2.2.7 U.S. cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.2.2.8 U.S. cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.2.3 Canada
- 8.2.3.1 Key Country Dynamics
- 8.2.3.2 Target Disease Prevalence
- 8.2.3.3 Competitive Scenario
- 8.2.3.4 Regulatory Framework
- 8.2.3.5 Reimbursement Scenario
- 8.2.3.6 Canada cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.2.3.7 Canada cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.2.3.8 Canada cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.2.1 SWOT Analysis
- 8.3 Europe
- 8.3.1 SWOT Analysis
- 8.3.1.1 Europe cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.3.1.2 Europe cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.3.1.4 Europe cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.3.2 Germany
- 8.3.2.1 Key Country Dynamics
- 8.3.2.2 Target Disease Prevalence
- 8.3.2.3 Competitive Scenario
- 8.3.2.4 Regulatory Framework
- 8.3.2.5 Reimbursement Scenario
- 8.3.2.6 Germany cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.3.2.7 Germany cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.3.2.8 Germany cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.3.3 U.K.
- 8.3.3.1 Key Country Dynamics
- 8.3.3.2 Target Disease Prevalence
- 8.3.3.3 Competitive Scenario
- 8.3.3.4 Regulatory Framework
- 8.3.3.5 Reimbursement Scenario
- 8.3.3.6 U.K. cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.3.3.7 U.K. cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.3.3.8 U.K. cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.3.4 France
- 8.3.4.1 Key Country Dynamics
- 8.3.4.2 Target Disease Prevalence
- 8.3.4.3 Competitive Scenario
- 8.3.4.4 Regulatory Framework
- 8.3.4.5 Reimbursement Scenario
- 8.3.4.6 France cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.3.4.7 France cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.3.4.8 France cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.3.5 Italy
- 8.3.5.1 Key Country Dynamics
- 8.3.5.2 Target Disease Prevalence
- 8.3.5.3 Competitive Scenario
- 8.3.5.4 Regulatory Framework
- 8.3.5.5 Reimbursement Scenario
- 8.3.5.6 Italy cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.3.5.7 Italy cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.3.5.8 Italy cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.3.6 Spain
- 8.3.6.1 Key Country Dynamics
- 8.3.6.2 Target Disease Prevalence
- 8.3.6.3 Competitive Scenario
- 8.3.6.4 Regulatory Framework
- 8.3.6.5 Reimbursement Scenario
- 8.3.6.6 Spain cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.3.6.7 Spain cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.3.6.8 Spain cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.3.7 Denmark
- 8.3.7.1 Key Country Dynamics
- 8.3.7.2 Target Disease Prevalence
- 8.3.7.3 Competitive Scenario
- 8.3.7.4 Regulatory Framework
- 8.3.7.5 Reimbursement Scenario
- 8.3.7.6 Denmark cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.3.7.7 Denmark cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.3.7.8 Denmark cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.3.8 Sweden
- 8.3.8.1 Key Country Dynamics
- 8.3.8.2 Target Disease Prevalence
- 8.3.8.3 Competitive Scenario
- 8.3.8.4 Regulatory Framework
- 8.3.8.5 Reimbursement Scenario
- 8.3.8.6 Sweden cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.3.8.7 Sweden cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.3.8.8 Sweden cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.3.9 Norway
- 8.3.9.1 Key Country Dynamics
- 8.3.9.2 Target Disease Prevalence
- 8.3.9.3 Competitive Scenario
- 8.3.9.4 Regulatory Framework
- 8.3.9.5 Reimbursement Scenario
- 8.3.9.6 Norway cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.3.9.7 Norway cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.3.9.8 Norway cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.3.1 SWOT Analysis
- 8.4 Asia Pacific
- 8.4.1 SWOT Analysis
- 8.4.1.1 Asia Pacific cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.4.1.2 Asia Pacific cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.4.1.3 Asia Pacific cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.4.2 Japan
- 8.4.2.1 Key Country Dynamics
- 8.4.2.2 Target Disease Prevalence
- 8.4.2.3 Competitive Scenario
- 8.4.2.4 Regulatory Framework
- 8.4.2.5 Reimbursement Scenario
- 8.4.2.6 Japan cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.4.2.7 Japan cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.4.2.8 Japan cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.4.3 China
- 8.4.3.1 Key Country Dynamics
- 8.4.3.2 Target Disease Prevalence
- 8.4.3.3 Competitive Scenario
- 8.4.3.4 Regulatory Framework
- 8.4.3.5 Reimbursement Scenario
- 8.4.3.6 China cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.4.3.7 China cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.4.3.8 China cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.4.4 India
- 8.4.4.1 Key Country Dynamics
- 8.4.4.2 Target Disease Prevalence
- 8.4.4.3 Competitive Scenario
- 8.4.4.4 Regulatory Framework
- 8.4.4.5 Reimbursement Scenario
- 8.4.4.6 India cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.4.4.7 India cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.4.4.8 India cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.4.5 South Korea
- 8.4.5.1 Key Country Dynamics
- 8.4.5.2 Target Disease Prevalence
- 8.4.5.3 Competitive Scenario
- 8.4.5.4 Regulatory Framework
- 8.4.5.5 Reimbursement Scenario
- 8.4.5.6 South Korea cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.4.5.7 South Korea cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.4.5.8 South Korea cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.4.6 Australia
- 8.3.9.1 Key Country Dynamics
- 8.4.6.2 Target Disease Prevalence
- 8.4.6.3 Competitive Scenario
- 8.4.6.4 Regulatory Framework
- 8.4.6.5 Reimbursement Scenario
- 8.4.6.6 Australia cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.4.6.7 Australia cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.4.6.8 Australia cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.4.7 Thailand
- 8.4.7.1 Key Country Dynamics
- 8.4.7.2 Target Disease Prevalence
- 8.4.7.3 Competitive Scenario
- 8.4.7.4 Regulatory Framework
- 8.4.7.5 Reimbursement Scenario
- 8.4.7.6 Thailand cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.4.7.7 Thailand cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.4.7.8 Thailand cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.4.1 SWOT Analysis
- 8.5 Latin America
- 8.5.1 SWOT Analysis
- 8.5.1.1 Latin America cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.5.1.2 Latin America cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.5.1.3 Latin America cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.5.2 Brazil
- 8.5.2.1 Key Country Dynamics
- 8.5.2.2 Target Disease Prevalence
- 8.5.2.3 Competitive Scenario
- 8.5.2.4 Regulatory Framework
- 8.5.2.5 Reimbursement Scenario
- 8.5.2.6 Brazil cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.5.2.7 Brazil cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.5.2.8 Brazil cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.5.3 Mexico
- 8.5.3.1 Key Country Dynamics
- 8.5.3.2 Target Disease Prevalence
- 8.5.3.3 Competitive Scenario
- 8.5.3.4 Regulatory Framework
- 8.5.3.5 Reimbursement Scenario
- 8.5.3.6 Mexico cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.5.3.7 Mexico cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.5.3.8 Mexico cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.5.4 Argentina
- 8.5.4.1 Key Country Dynamics
- 8.5.4.2 Target Disease Prevalence
- 8.5.4.3 Competitive Scenario
- 8.5.4.4 Regulatory Framework
- 8.5.4.5 Reimbursement Scenario
- 8.5.4.6 Argentina cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.5.4.7 Argentina cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.5.4.8 Argentina cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.5.1 SWOT Analysis
- 8.6 MEA
- 8.6.1 SWOT Analysis
- 8.6.1.1 MEA cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.6.1.2 MEA cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.6.1.3 MEA cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.6.2 South Africa
- 8.6.4.1 Key Country Dynamics
- 8.6.2.2 Target Disease Prevalence
- 8.6.2.3 Competitive Scenario
- 8.6.2.4 Regulatory Framework
- 8.6.2.5 Reimbursement Scenario
- 8.6.2.6 Argentina cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.6.2.7 Argentina cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.6.2.8 Argentina cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.6.3 Saudi Arabia
- 8.6.3.1 Key Country Dynamics
- 8.6.3.2 Target Disease Prevalence
- 8.6.3.3 Competitive Scenario
- 8.6.3.4 Regulatory Framework
- 8.6.3.5 Reimbursement Scenario
- 8.6.3.6 Saudi Arabia cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.6.3.7 Saudi Arabia cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.6.3.8 Saudi Arabia cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.6.4 UAE
- 8.6.4.1 Key Country Dynamics
- 8.6.4.2 Target Disease Prevalence
- 8.6.4.3 Competitive Scenario
- 8.6.4.4 Regulatory Framework
- 8.6.4.5 Reimbursement Scenario
- 8.6.4.6 UAE cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.6.4.7 UAE cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.6.4.8 UAE cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.6.5 Kuwait
- 8.6.5.1 Key Country Dynamics
- 8.6.5.2 Target Disease Prevalence
- 8.6.5.3 Competitive Scenario
- 8.6.5.4 Regulatory Framework
- 8.6.5.5 Reimbursement Scenario
- 8.6.5.6 Kuwait cell viability assay market, by product, 2018 - 2030 (USD Million)
- 8.6.5.7 Kuwait cell viability assay market, by application, 2018 - 2030 (USD Million)
- 8.6.5.8 Kuwait cell viability assay market, by end-user, 2018 - 2030 (USD Million)
- 8.6.1 SWOT Analysis
Chapter 9 Competitive Landscape
- 9.1 Participant's overview
- 9.1.1 Thermo Fisher Scientific Inc.
- 9.1.2 Agilent Technologies, Inc.
- 9.1.3 Bio-Rad Laboratories Inc.
- 9.1.4 Merck KGaA
- 9.1.5 BD
- 9.1.6 PerkinElmer Inc.
- 9.1.7 Promega Corporation
- 9.1.8 Biotium
- 9.1.9 Creative Bioarray
- 9.1.10 Abcam Plc
- 9.1.11 Charles River Laboratories
- 9.2 Financial performance
- 9.3 Participant categorization
- 9.3.1 Market leaders
- 9.3.1.1 Cell viability assay market share analysis, 2022
- 9.3.2 Strategy mapping
- 9.3.2.1 Expansion
- 9.3.2.2 Acquisition
- 9.3.2.3 Collaborations
- 9.3.2.4 Product/service launch
- 9.3.2.5 Partnerships
- 9.3.2.6 Others
- 9.3.1 Market leaders
Product Code: GVR-4-68040-008-0
List of Tables
- Table 1. List of secondary sources
- Table 2. List of abbreviations
- Table 3. Global cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 4. Global cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 5. Global cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 6. Global cell viability assay market, by region, 2018 - 2030 (USD Million)
- Table 7. North America cell viability assay market, by country, 2018 - 2030 (USD Million)
- Table 8. North America cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 9. North America cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 10. North America cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 11. U.S. Cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 12. U.S. Cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 13. U.S. Cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 14. Canada cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 15. Canada cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 16. Canada cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 17. Europe cell viability assay market, by country, 2018 - 2030 (USD Million)
- Table 18. Europe cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 19. Europe cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 20. Europe cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 21. U.K. cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 22. U.K. cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 23. U.K. cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 24. Germany cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 25. Germany cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 26. Germany cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 27. France cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 28. France cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 29. France cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 30. Italy cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 31. Italy cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 32. Italy cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 33. Spain cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 34. Spain cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 35. Spain cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 36. Denmark cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 37. Denmark cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 38. Denmark cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 39. Sweden cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 40. Sweden cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 41. Sweden cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 42. Norway cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 43. Norway cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 44. Norway cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 45. Asia Pacific cell viability assay market, by country, 2018 - 2030 (USD Million)
- Table 46. Asia Pacific cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 47. Asia Pacific cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 48. Asia pacific cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 49. China cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 50. China cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 51. China cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 52. India cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 53. India cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 54. India cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 55. Japan cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 56. Japan cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 57. Japan cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 58. Thailand cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 59. Thailand cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 60. Thailand cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 61. Australia cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 62. Australia cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 63. Australia cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 64. South Korea cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 65. South Korea cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 66. South Korea cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 67. Latin America cell viability assay market, by country, 2018 - 2030 (USD Million)
- Table 68. Latin America cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 69. Latin America cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 70. Latin America cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 71. Brazil cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 72. Brazil cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 73. Brazil cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 74. Mexico cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 75. Mexico cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 76. Mexico cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 77. Argentina cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 78. Argentina cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 79. Argentina cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 80. Middle East & Africa cell viability assay market, by country, 2018 - 2030 (USD Million)
- Table 81. Middle East & Africa cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 82. Middle East & Africa cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 83. Middle East & Africa cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 84. South Africa cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 85. South Africa cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 86. South Africa cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 87. Saudi Arabia cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 88. Saudi Arabia cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 89. Saudi Arabia cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 90. UAE cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 91. UAE cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 92. UAE cell viability assay market, end-user, 2018 - 2030 (USD Million)
- Table 93. Kuwait cell viability assay market, by product, 2018 - 2030 (USD Million)
- Table 94. Kuwait cell viability assay market, by application, 2018 - 2030 (USD Million)
- Table 95. Kuwait cell viability assay market, end-user, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information procurement
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Value chain-based sizing & forecasting
- Fig. 6 Market formulation & validation
- Fig. 7 Cell viability assay, market segmentation
- Fig. 8 Market snapshot, 2021
- Fig. 9 Market trends & outlook
- Fig. 10 Market driver relevance analysis (current & future impact)
- Fig. 11 Market restraint relevance analysis (current & future impact)
- Fig. 12 Market challenge relevance analysis (current & future impact)
- Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
- Fig. 14 Porter's five forces analysis
- Fig. 15 Market penetration vs growth prospect mapping, 2021
- Fig. 16 Global cell viability assay market: product movement analysis
- Fig. 17 Global cell viability assay market, for consumables, 2018 - 2030 (USD Million)
- Fig. 18 Global cell viability assay market, for reagents and assay kits, by type, 2018 - 2030 (USD Million)
- Fig. 19 Global cell viability assay market, for dye exclusion assays, 2018 - 2030 (USD Million)
- Fig. 20 Global cell viability assay market, for colorimetric assays, 2018 - 2030 (USD Million)
- Fig. 21 Global cell viability assay market, for fluorometric assays, 2018 - 2030 (USD Million)
- Fig. 22 Global cell viability assay market, for luminometric assays, 2018 - 2030 (USD Million)
- Fig. 23 Global cell viability assay market, for microplates, 2018 - 2030 (USD Million)
- Fig. 24 Global cell viability assay market, for insturments, 2018 - 2030 (USD Million)
- Fig. 25 Global cell viability assay market, for spectrophotometer, 2018 - 2030 (USD Million)
- Fig. 26 Global cell viability assay market, for microscopy, 2018 - 2030 (USD Million)
- Fig. 27 Global cell viability assay market, for cell imaging and analysis system, 2018 - 2030 (USD Million)
- Fig. 28 Global cell viability assay market, for others, 2018 - 2030 (USD Million)
- Fig. 29 Global cell viability assay market, for microplates, 2018 - 2030 (USD Million)
- Fig. 30 Global cell viability assay market: application movement analysis
- Fig. 31 Global cell viability assay market, for drug discovery and development, 2018 - 2030 (USD Million)
- Fig. 32 Global cell viability assay market, for stem cell research, 2018 - 2030 (USD Million)
- Fig. 33 Global cell viability assay market, for stem cell research, 2018 - 2030 (USD Million)
- Fig. 34 Global cell viability assay market: end-user movement analysis
- Fig. 35 Global cell viability assay market, for biopharmaceutical & pharmaceutical companies, 2018 - 2030 (USD Million)
- Fig. 36 Global cell viability assay market, for CROSs & CMOs, 2018 - 2030 (USD Million)
- Fig. 37 Global cell viability assay market, for academic & research institutes, 2018 - 2030 (USD Million)
- Fig. 38 Global cell viability assay market, for diagnostic labs, 2018 - 2030 (USD Million)
- Fig. 39 Regional marketplace: key takeaways
- Fig. 40 Regional outlook, 2021 & 2030
- Fig. 41 Global flow cytometry market: regional movement analysis
- Fig. 42 North America cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 43 U.S. Cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 44 Canada cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 45 Europe cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 46 U.K. cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 47 Germany cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 48 France cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 49 Italy cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 50 Spain cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 51 Denmark cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 52 Sweden cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 53 Norway cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 54 Asia pacific cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 55 China cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 56 India cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 57 Japan cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 58 Thailand cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 59 Australia cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 60 South Korea cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 61 Latin America cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 62 Brazil cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 63 Mexico cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 64 Argentina cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 65 Middle East and Africa cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 66 South Africa cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 67 Saudi Arabia cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 68 UAE cell viability assay market, 2018 - 2030 (USD Million)
- Fig. 69 Kuwait cell viability assay market, 2018 - 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.